Patterson Companies — JP Morgan Healthcare Conference January 2017
32 slides from Patterson Companies's conference presentation, Jan 10, 2017
Slide 1: JP Morgan Healthcare Conference January 2017
JP Morgan Healthcare Conference January 2017 Scott P. Anderson Chairman, President and CEO, Patterson Companies Exhibit 99
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT This presentation contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond Patterson's abilit
Slide 3: Positioned for Profitable Growth
POSITIONED FOR PROFITABLE GROWTH Large, stable markets Strong growth catalysts Refined market focus, more synergistic business segments Strategic vendor partnerships, industry-leading technology Best-in-class service and after-sales support Enhanced ability to generate cash, drive shareholder value
Slide 4: Purpose: Connecting Expertise to Inspired Ideas
Connecting EXPERTISE to INSPIRED IDEAS, products and services Creating a RELEVANT, MEMORABLE DIFFERENCE in the lives of our clients and their customers PURPOSE
Slide 5: Two Market Leading Businesses
~ 40% Market Share: US Production Animal ~ 25% Market Share: US Companion Animal ~ 40% Market Share: UK Animal Health 47% of Revenues ~ 33% Market Share: North America Dental TWO MARKET LEADING BUSINESSES DENTAL 53% of Revenues ANIMAL HEALTH
Slide 6: Shared Market Characteristics
SHARED MARKET CHARACTERISTICS Dental Animal Health Evolving Customer Base Desire for Innovation and Technology Need for Business Support Services Distributor Supplies Small Percentage of Total Customer Spend
Slide 7: Shared Operational Characteristics
SHARED OPERATIONAL CHARACTERISTICS PRIVATE PRACTICE OWNERS (both segments) Entrepreneurial spirit Minimal back office support Our sales force serves as business partner High importance on value added services LARGE GROUP / EQUITY OWNERS (both segments) Driven to improve efficiency Need for business
Slide 8: Focused Position to Meet Their Needs
FOCUSED POSITION TO MEET THEIR NEEDS PRIVATE PRACTICE OWNERS (both segments) Specialized sales force Technology expertise After sales training and support E-commerce platform Decentralized structure Excellence in logistics LARGE GROUP / EQUITY OWNERS (both segments) Small Vet Clinics Private Practic
Slide 9: Excellence in Logistics
EXCELLENCE IN LOGISTICS MORE THAN 1,400 ASSOCIATES 2.6 MILLION TOTAL SQUARE FEET 23,000 ORDERS PER DAY 79 FACILITIES 500 FLEET AND LTL DELIVERIES DAILY 96% OF CUSTOMER BASE SERVICED WITH ONE-DAY GROUND MORE THAN 43,000 PACKAGES SHIPPED DAILY
Slide 10: ERP Implementation Update
ERP IMPLEMENTATION UPDATE System “stabilized” quickly after Pilot 9 locations operational Centralized returns for SAP branches Branches now embracing cutover with distribution centers COMPLETED FY17 Q2 FY18 2H FY19 25% increase in order filling productivity Pick-to-box significantly reduces packing
Slide 11: Patterson Dental Today
PATTERSON DENTAL TODAY $2.5B ANNUAL REVENUE FISCAL 2016 Patterson Dental provides differentiated products, services and solutions – partnering with all oral health professionals, creating an improved patient experience and practice lifestyle. $2.5B DENTAL SALES 56% Consumables 33% Equipment and Tech
Slide 12: Strong North American Dental Opportunity
STRONG NORTH AMERICAN DENTAL OPPORTUNITY Large, stable market with promising demographic trends Dental practice design evolving to address the needs of today’s consumer Digital technology transforming dental practices – as technology expands, we become more valuable through: Innovative digital techn
Slide 13: Partner of Choice
850+ territory reps 80+ CEREC specialists 150+ equipment specialists 400+ support people at Patterson Technology Center 900+ service techs 16 training facilities 100+ implementation specialists 300+ certified clinical trainers PARTNER OF CHOICE Best-in-class North American sales, training and techni
Slide 14: Patterson Dental – Focused on Growth
PATTERSON DENTAL – FOCUSED ON GROWTH OUR PRIMARY GROWTH DRIVERS Mid Market and DSO penetration Adoption of digital workflow Core equipment innovation and facility transformation Technical service and training support expansion
Slide 15: Patterson Dental – Looking Ahead
PATTERSON DENTAL – LOOKING AHEAD Grow market share (private practices, group/corporate practices, dental specialists) Expand leadership in digital technology platforms Leverage service training and support infrastructure Complete ERP initiative to leverage efficiency and market opportunities Grow th
Slide 16: Patterson Animal Health Today
PATTERSON ANIMAL HEALTH TODAY $2.9B ANNUAL REVENUE FISCAL 2016 A leading distributor of products, services and technologies to both the production and companion animal health markets in North America and the U.K. $2.9B 54% Companion 16% Beef 12% Dairy 10% Swine 8% Other ANIMAL HEALTH SALES
Slide 17: Compelling Growth Catalysts in Companion Animal
Est. expenditures by pet owners in 2014, up from $41B in 2007 (APPA) $59B PET EXPENDITURES U.S. households that own a pet, compared to 56% in 1988 (APPA) 68% PET OWNERSHIP COMPELLING GROWTH CATALYSTS IN COMPANION ANIMAL
Slide 18: Compelling Growth Catalysts in Production Animal
COMPELLING GROWTH CATALYSTS Global production animal health market projected CAGR of 5% 100% expansion in animal protein production needed to support trends Today 2050 7.0B 9.0B Global Population Today 2050 1.8B 4.8B Global Middle Class IN PRODUCTION ANIMAL 2 billion increase Nearly tripling in size
Slide 19: Patterson Animal Health as a Single Platform
PATTERSON ANIMAL HEALTH AS A SINGLE PLATFORM Broad coverage in all species Market leader in beef, dairy, swine and dealer markets across multiple product categories Strong long-term relationships with diversified customer base Deep product portfolio and value-added services Significant revenue and o
Slide 20: Largest Animal Health Distributor in the U.S.
LARGEST ANIMAL HEALTH DISTRIBUTOR IN THE U.S. CY 2015 Patterson Animal Health Market Share by Species (Production and Companion) CY 2015 Patterson Animal Health Market Share by Product (Production and Companion) 50% 25% 0% 0 50% 25% 0% 37% Antibiotics Hormones Vaccines Pharma Others Anti-Parasitics
Slide 21: Strategic Priorities – Animal Health
STRATEGIC PRIORITIES Leverage increased benefits and scale efficiencies with customers and industry partners Increase market penetration with integrated platform Expand private label, proprietary product lines Grow through organic expansion and targeted acquisitions Promote technology and service of
Slide 22: JP Morgan Healthcare Conference January 2017 – CFO
JP Morgan Healthcare Conference January 2017 Ann B. Gugino EVP and CFO, Patterson Companies
Slide 23: Financial Platform Strengths
FINANCIAL PLATFORM STRENGTHS Disciplined investments for future growth and efficiency Strong, stable cash flow to fund capital allocation strategy Conservative, well-capitalized balance sheet Multi-pronged capital allocation strategy Financial flexibility
Slide 24: Bridge to Revised Guidance
~ Half Dental Consumable market softness Change in Sirona relationship ~ Half Animal Health Branded pharma Sales execution Cost management Contract discussions Working capital improvement Additional synergy capture BRIDGE TO REVISED GUIDANCE 2H FOCUS AREAS ON NOVEMBER 22, 2016 PATTERSON PROVIDED FY1
Slide 25: FY17 GAAP to Non-GAAP Reconciliation
FY17 GAAP to Non-GAAP Reconciliation GUIDANCE ASSUMPTIONS Continuing operations as well as completed or previously announced acquisitions. Excludes new acquisitions. North American and international market conditions similar to first half of FY 2017. Excludes transaction-related costs, integration a
Slide 26: FY17 and FY18 EPS Headwinds
FY17 and FY18 EPS headwinds SAP implementation, Sirona relationship change, Animal Heath margins Executional focus Distribution efficiencies Focus on procurement Working capital reduction Expense management Synergy capture in Animal Health Optimizing capital structure Liquidity flexibility to return
Slide 27: FY19 and Beyond
FY19 and Beyond EPS adjusted growth of 8-10% Realizing benefits of ERP across entire workflow Strong free cash flow and greater conversion of net income to cash Drive additional strategies to unlock shareholder value
Slide 28: Capital Allocation Priorities
$1.3B Expectation for free cash flow over next 5 years CAPITAL ALLOCATION PRIORITIES Investing for growth – organic and acquisition opportunities Repurchasing shares Growing the dividend FREE CASH FLOW* ($M) *Free Cash Flow is defined as Operating Cash Flow less Cap Ex
Slide 29: Cash Returned to Shareholders
91 200 82 48 96 86 43 179 55 362 50 97 Share Repurchases Dividends CASH RETURNED TO SHAREHOLDERS ($M)
Slide 30: 5-Year Financial Objectives 2017-2021
AGGRESSIVE, YET REALISTIC ORGANIC TARGETS 85% - 100% 5-YEAR FINANCIAL OBJECTIVES 2017-2021
Slide 31: Positioned for Profitable Growth
POSITIONED FOR PROFITABLE GROWTH Large, stable markets Strong growth catalysts Refined market focus, more synergistic business segments Strategic vendor partnerships, industry-leading technology Best-in-class service and after-sales support Enhanced ability to generate cash, drive shareholder value
Slide 32: Strong Foundation Bold Future
STRONG FOUNDATION BOLD FUTURE
Patterson Companies — JP Morgan Healthcare Conference January 2017 on 6ix